Design, synthesis and biological evaluation of ezrin inhibitors targeting metastatic osteosarcoma.

[1]  A. Üren,et al.  Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells , 2012, Oncogene.

[2]  K. Morimoto,et al.  The synthetic and biological studies of discorhabdins and related compounds. , 2011, Organic & biomolecular chemistry.

[3]  A. Üren,et al.  A real-time electrical impedance based technique to measure invasion of endothelial cell monolayer by cancer cells. , 2011, Journal of visualized experiments : JoVE.

[4]  S. Arold,et al.  Phosphatidylinositol 4,5-bisphosphate-induced conformational change of ezrin and formation of ezrin oligomers. , 2010, Biochemistry.

[5]  Ajit Varki,et al.  Molecular basis of metastasis. , 2009, The New England journal of medicine.

[6]  S. Hewitt,et al.  The actin-cytoskeleton linker protein ezrin is regulated during osteosarcoma metastasis by PKC , 2009, Oncogene.

[7]  C. Klein,et al.  The Metastasis Cascade , 2008, Science.

[8]  L. Whitesell,et al.  Discovery of quinolinediones exhibiting a heat shock response and angiogenesis inhibition. , 2008, Journal of medicinal chemistry.

[9]  C. Ryu,et al.  Synthesis and antifungal activity of 6-arylamino-phthalazine-5,8-diones and 6,7-bis(arylthio)-phthalazine-5,8-diones. , 2007, Bioorganic & medicinal chemistry letters.

[10]  S. Danishefsky,et al.  Chemistry and biology in search of antimetastatic agents. , 2007, ACS chemical biology.

[11]  G. Christofori.  New signals from the invasive front , 2006, Nature.

[12]  Tse-Ching Chen,et al.  Significance of cellular distribution of ezrin in pancreatic cystic neoplasms and ductal adenocarcinoma. , 2005, Archives of surgery.

[13]  A. Gomtsyan,et al.  Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties. , 2005, Journal of medicinal chemistry.

[14]  S. Duke,et al.  Structural activity relationship studies of zebra mussel antifouling and antimicrobial agents from verongid sponges. , 2004, Journal of Natural Products.

[15]  M. Gebhardt,et al.  Biology and therapeutic advances for pediatric osteosarcoma. , 2004, The oncologist.

[16]  Javed Khan,et al.  Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators , 2004, Nature Medicine.

[17]  Stephen M Hewitt,et al.  The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis , 2004, Nature Medicine.

[18]  ウィリアム・グレン・ホロウェイ,et al.  Diaryl ethers as opioid receptor antagonists , 2003 .

[19]  P. Karplus,et al.  Structure of the Active N-terminal Domain of Ezrin , 2003, The Journal of Biological Chemistry.

[20]  B. Ganem,et al.  Cytotoxic, antifouling bromotyramines: a synthetic study on simple marine natural products and Their analogues. , 2002, Bioorganic & medicinal chemistry letters.

[21]  P. Meltzer,et al.  Metastasis-associated differences in gene expression in a murine model of osteosarcoma. , 2001, Cancer research.

[22]  D. Nance,et al.  Interactions between cancer cells and the endothelium in metastasis , 2000, The Journal of pathology.

[23]  T. Matsui,et al.  Activation of ERM proteins in vivo by Rho involves phosphatidyl-inositol 4-phosphate 5-kinase and not ROCK kinases , 1999, Current Biology.

[24]  M. Hollingsworth,et al.  High levels of ezrin expressed by human pancreatic adenocarcinoma cell lines with high metastatic potential. , 1999, Biochemical and biophysical research communications.

[25]  A. Vaheri,et al.  Association of Ezrin with Intercellular Adhesion Molecule-1 and -2 (ICAM-1 and ICAM-2) , 1998, The Journal of Biological Chemistry.

[26]  O. Hoshino,et al.  STUDIES ON SYNTHESIS OF ARAPLYSILLINS VIA OXIDATIVE CYCLISATION OF O-PHENOLIC OXIME-ACID DERIVATIVES USING PHENYLIODONIUM DIACETATE , 1998 .

[27]  S. Tsukita,et al.  ERM (ezrin/radixin/moesin) family: from cytoskeleton to signal transduction. , 1997, Current opinion in cell biology.

[28]  Y. Kita,et al.  An Intramolecular Cyclization of Phenol Derivatives Bearing Aminoquinones Using a Hypervalent Iodine Reagent. , 1996 .

[29]  N. Sato,et al.  ERM family members as molecular linkers between the cell surface glycoprotein CD44 and actin-based cytoskeletons , 1994, The Journal of cell biology.

[30]  A. Huvos,et al.  Osteogenic sarcoma with clinically detectable metastasis at initial presentation. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  J. Parrick,et al.  Studies of phthalazine-5,8-quinone, A ring contraction, and some novel and potentially useful fluorescent phthalimides , 1993 .

[32]  I. Fidler,et al.  Cancer metastasis. , 1991, British medical bulletin.

[33]  R. Barret,et al.  Oxidation of phenols to quinones by bis(trifluoroacetoxy)iodobenzene. , 2010 .

[34]  A. Grollman,et al.  Streptonigrin. 1. Structure-activity relationships among simple bicyclic analogues. Rate dependence of DNA degradation on quinone reduction potential. , 1986, Journal of medicinal chemistry.

[35]  D. Boger,et al.  Inverse electron demand Diels-Alder reactions of heterocyclic azadienes. Studies on the total synthesis of lavendamycin: investigative studies on the preparation of the CDE .beta.-carboline ring system and AB quinoline-5,8-quinone ring system , 1985 .

[36]  W. Denny,et al.  Potenial antitumor agents. 28. Deoxyribonucleic acid polyintercalating agents. , 1978, Journal of medicinal chemistry.